Extended Use of Penicillin G Benzathine (Bicillin L-A) - Recommending Limiting Doses to Treating Pregnant Women

There is an ongoing national shortage of Bicillin L-A, following the voluntary recall by King Pharmaceuticals Inc., a subsidiary of Pfizer, of Bicillin L-A (Penicillin G Benzathine Injectable Suspension) in July 2025.

Medical providers should continue to prioritize the use of Bicillin L-A for women who are diagnosed with or suspected of having syphilis and who are pregnant. Read more.